Immediate Impact
2 by Nobel laureates 3 from Science/Nature 54 standout
Citing Papers
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Immunogenicity of Extracellular Vesicles
2024 Standout
Works of Harsh B. Pathak being referenced
WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1
2021
Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer.
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Harsh B. Pathak | 661 | 384 | 223 | 365 | 65 | 1.5k | |
| Benedict Yan | 989 | 482 | 261 | 239 | 70 | 2.0k | |
| Michael Agrez | 573 | 500 | 406 | 215 | 66 | 1.8k | |
| Takeshi Sato | 297 | 209 | 72 | 93 | 80 | 1.3k | |
| Yuichiro Hatano | 390 | 421 | 139 | 49 | 63 | 1.2k | |
| Lotte K. Vogel | 761 | 478 | 291 | 96 | 59 | 2.0k | |
| Sarah Watson | 506 | 403 | 139 | 107 | 72 | 1.5k | |
| Alexandros D. Polydorides | 613 | 333 | 137 | 33 | 83 | 2.1k | |
| Andrew C. Nelson | 627 | 414 | 187 | 81 | 78 | 1.9k | |
| Frank M. van den Berg | 911 | 804 | 291 | 66 | 41 | 2.1k | |
| Eiko Hidaka | 994 | 156 | 111 | 22 | 82 | 2.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...